Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Pavan, R.; Jain, S.; Shraddha, S.; Kumar, A.
    Properties and therapeutic application of bromelain: a review (2012), Biotechnol. Res. Int., 2012, 976203.
    View publication on PubMedView publication on EuropePMC

Application

EC Number Application Comment Organism
3.4.22.32 medicine bromelain relieves osteoarthritis. Bromelain is used as an adjuvant therapeutic approach in the treatment of chronic inflammatory, malignant, and autoimmune diseases. Bromelain prevents or minimizes the severity of angina pectoris and transient ischemic attack. Bromelain influences blood coagulation by increasing the serum fibrinolytic ability and by inhibiting the synthesis of fibrin. Bromelain counteracts some of the effects of certain intestinal pathogens like Vibrio cholera and Escherichia coli, whose enterotoxin causes diarrhea. The anticancerous activity of bromelain is due to its direct impact on cancer cells and their microenvironment, as well as on the modulation of immune, inflammatory, and haemostatic systems. Bromelain is used for treating acute inflammation and sports injuries. Bromelain applied as a cream (35% bromelain in a lipid base) can be beneficial for debridement of necrotic tissue and acceleration of healing Ananas comosus

Organism

EC Number Organism UniProt Comment Textmining
3.4.22.32 Ananas comosus
-
-
-

Source Tissue

EC Number Source Tissue Comment Organism Textmining
3.4.22.32 stem
-
 Ananas comosus
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.4.22.32 casein + H2O
-
 Ananas comosus ?
-
 ?
3.4.22.32 Gelatin + H2O
-
 Ananas comosus ?
-
 ?

Synonyms

EC Number Synonyms Comment Organism
3.4.22.32 Bromelain
-
 Ananas comosus